Last updated on February 2018

Hybrid Catheter Ablation for Persistent Atrial Fibrillation

Brief description of study

prospective randomized controlled trial

In repeat procedure for persistent atrial fibrillation, Hybrid group (Epicardial ablation + Endocardial ablation) versus control group (conventional Endocardial ablation)

Freedom from AF/Atrial tachycardia and safety

Detailed Study Description

Epicardial (EPI) catheter approach is considered as an accessory to endocardial (ENDO) ablation for persistent atrial fibrillation (PeAF). We evaluated the effectiveness and safety of EPI ablation as first option to the patients who had previous endocardial ablation for PeAF.

This is prospective randomized controlled, single center study. study population is recurred AF patient with failed previous ENDO catheter ablation for PeAF. The investigators randomized study population to both groups: Hybrid group (EpI + ENDO ablation) versus control group (conventional ENDO ablation). Clinical outcome (Freedom from AF/Atrial tachycardia) and procedural safety will be compared.

Clinical Study Identifier: NCT02979847

Contact Investigators or Research Sites near you

Start Over

Young-Hoon Kim, President

Korea University Medical Center Anam hospital
Seoul, Korea, Republic of
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.